针对肝脏慢性病毒感染的宿主向抗病毒药物
Nicola Frericks1, Mara Klöhn1, Frauke Lange2
1Department of Molecular and Medical Virology, Ruhr University Bochum, Bochum, Germany.
Antiviral research
|December 24, 2024
概括
针对宿主的抗病毒药物 (HTA) 提供了针对慢性乙型肝炎 (HBV),C型肝炎 (HCV) 和D型肝炎 (HDV) 感染的新策略,解决了当前治疗方法的局限性. 本综述探讨了HBV,HDV,HCV的HTA,以及E型肝炎 (HEV) 的新兴选择.
科学领域:
- 病毒学和肝病学.
- 药物发现和开发 药物发现和开发
背景情况:
- 肝炎病毒 (HAV,HBV,HCV,HDV,HEV) 导致严重的肝病和肝细胞癌的风险.
- 慢性HBV和HCV感染是全球主要的健康负担,HDV的同时感染特别严重.
- 虽然直接作用抗病毒药物 (DAA) 已经推进了HCV和HBV治疗,但药物耐药性和对HDV/HEV缺乏选择等挑战仍然存在.
研究的目的:
- 审查针对慢性HBV/HDV和HCV感染的宿主向抗病毒药物 (HTA) 的研究和开发里程碑.
- 总结有关HEV感染治疗宿主向选择的当前知识.
主要方法:
- 对肝炎病毒的HTA研究和开发的综合文献综述.
- 对HBV,HCV,HDV和HEV的当前治疗策略和挑战的分析.
主要成果:
- HTAs通过向病毒复制必不可少的宿主细胞通路,代表了DAA的有希望的替代品.
- 在治疗慢性HBV,HDV和HCV感染的HTA开发方面取得了显著进展.
- 新兴的宿主向策略显示出管理HEV感染的潜力,包括免疫功能低下个体的慢性病例.
结论:
- HTA为病毒性肝炎提供了一种新的治疗途径,有可能克服现有的抗病毒疗法的局限性.
- 对HTA的进一步研究和临床开发对于有效管理慢性病毒性肝炎和HEV至关重要.
- 调节宿主细胞通路为开发针对各种各样的肝炎病毒的新抗病毒治疗提供了一个多功能平台.
相关概念视频
Retrovirus Life Cycles
45.6K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.6K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
531
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
531
Immune Response Against Viral Pathogens
745
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
745
siRNA - Small Interfering RNAs
16.6K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.6K


